NASDAQ:MCRB - Seres Therapeutics, Inc.
$6.90
 $0.06
+0.88%
4:00PM EDT
2019-04-18
Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens. The Company is also conducting research on metabolic diseases, such as early-stage, non-insulin dependent diabetes; non-alcoholic steatohepatitis, and obesity and metabolic syndrome.As of December 31, 2016, the Company's SER-109, a bacterial spore ecology, consisted of an average of approximately 50 bacterial species derived from healthy donors' fecal matter. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MCRB     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 19   203. 85   241. 91  
42 stocks rank:  4. 17 K 1. 44 K 1. 05 K
# analyst opinions:  6. 00   14. 51   13. 97  
mean recommendation:  1. 90   2. 09   2. 01  

quick ratio:  2. 04   5. 27   1. 81  
current ratio:  2. 20   5. 62   2. 25  

target price low:  8. 00   84. 80   115. 21  
target price avg:  13. 00   111. 51   137. 51  
target price high:  15. 00   135. 81   157. 84  
1-yr high:  9. 55   114. 23   138. 78  
last close:  6. 90   87. 66   116. 69  
50-day avg:  6. 36   95. 54   123. 44  
200-day avg:  7. 03   94. 25   121. 11  
1-yr low:  4. 52   72. 78   98. 34  
volume:  97. 91 K 4. 11 M 8. 07 M
50-day avg volume:  426. 89 K 2. 76 M 5. 02 M
200-day avg volume:  185. 84 K 2. 92 M 4. 59 M

1-day return:  0. 88 % -0. 41 % 0. 07 %
this week return:  1. 62 % -5. 74 % -4. 11 %
12-wk return:  14. 81 % 1. 61 % -0. 05 %
52-wk return:  -10. 12 % 3. 12 % 8. 78 %

enterprise value (EV):  197. 41 M 48. 94 B 114. 64 B
market cap:  283. 23 M 43. 07 B 104. 73 B
EBITDA:  -92. 42 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -2. 14   4. 22   12. 73  
enterprise/revenue (EV/R):  6. 98   63. 17   12. 84  
total revenue:  28. 27 M 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -98. 94 M 2. 20 B 4. 20 B

shares outstanding:  41. 05 M 571. 70 M 1. 24 B
shares:  20. 97 M 571. 81 M 1. 23 B
shares short:  5. 18 M 10. 17 M 13. 00 M
shares short prior month:  3. 97 M 9. 54 M 17. 33 M
short ratio:  6. 68   5. 41   3. 28  
short % of float:  36. 14 % 5. 45 % 2. 38 %
total cash/share:  2. 09   11. 14   9. 33  
total cash:  85. 82 M 6. 71 B 7. 15 B
free cash flow:  -31. 45 M 3. 58 B 2. 96 B
operating cash flow:  -62. 85 M 4. 15 B 4. 30 B

book value:  -1. 17   12. 78   26. 92  
price/book:  -5. 88   3. 06   -1. 74  
gross profits:  -67. 69 M 8. 04 B 34. 86 B
operating margins:  -354. 77 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  -239. 46 % 37. 08 % 55. 70 %

1-yr max volatility:  24. 85 % --- ---
1-yr mean volatility:  0. 04 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 43   2. 40   4. 10  
forward EPS:  -1. 78   3. 97   7. 13  
P/E:  -2. 84   13. 63   22. 72  
forward P/E:  -3. 88   -15. 95   13. 99  
PE/G:  -0. 01   -1. 65   -1. 32  
growth:  247. 80 % 127. 12 % 29. 61 %
earnings high:  0. 21   1. 00   1. 66  
earnings avg:  -0. 34   0. 77   1. 53  
earnings low:  -0. 72   0. 50   1. 39  
revenue high:  43. 00 M 2. 68 B 10. 78 B
revenue avg:  17. 07 M 2. 59 B 10. 57 B
revenue low:  4. 00 M 2. 49 B 10. 36 B
return on assets:  -40. 44 % -2. 75 % 4. 55 %
return on equity:  -1563. 81 % -18. 45 % 5. 46 %
revenue growth:  247. 80 % 92. 86 % 18. 96 %
revenue/share:  0. 69   13. 29   55. 46  

beta (1yr vs S&P500):  1. 50   1. 25   0. 93  
sharpe (1yr):  0. 15   0. 37   0. 70  

held % insiders:  17. 50 % 6. 39 % 3. 38 %
held % institutions:  77. 62 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : MCRB
.    + 0.199 =         0.199 :: INITIAL WEIGHT
.   + 37.825 =        38.024 :: spline projection addition
.    x 1.431 =        54.429 :: industry recommendation factor
.    x 2.303 =       125.374 :: symbol recommendation factor
.    x 1.111 =       139.235 :: EV/R factor
.    x 0.996 =       138.671 :: return on assets factor
.    x 0.844 =       116.986 :: return on equity factor
.    x 2.508 =       293.447 :: revenue growth factor
.    x 2.392 =        701.89 :: current ratio factor
.      x 1.4 =         982.8 :: quick ratio factor
.    x 1.072 =      1053.798 :: short ratio factor
.    x 1.941 =      2045.661 :: price-to-book factor
.    x 1.079 =      2208.117 :: 5-day avg > 50-day avg
.    x 2.128 =      4698.385 :: P/E weight
.    x 2.209 =      10378.54 :: PE/G factor
.    x 1.353 =     14043.439 :: beta factor
.    x 0.153 =      2143.148 :: sharpe factor
.    x 1.409 =      3019.143 :: target low factor
.    x 1.313 =      3965.386 :: target mean factor
.    x 1.108 =      4395.025 :: target high factor
.     x 1.31 =       5756.99 :: industry 2-weeks return factor
.    x 0.953 =      5485.435 :: overall "drift" factor
.    x 0.751 =      4122.127 :: largest single-day jump factor
.    x 0.097 =       400.985 :: low price factor
.      x 1.0 =        400.92 :: factor hist industry gain for week 16
.   cubeRoot =         7.374 :: reduced to standardize
.   - 22.414 =         0.194 :: add/subtract for performance
.                      0.194 :: FINAL WEIGHT for NASDAQ:MCRB


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org